Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...

Celltrion has launched Steqeyma (ustekinumab-stba), its biosimilar of Stelara (ustekinumab), at list price at an 85% discount ...

Express Scripts, Caremark and Optum Rx are turning to an appeals court to ... Pharmaceutical companies increase the list price of insulin as a result, according to the FTC. Anticompetitive ...

That preference drives drugmakers to increase the list price of their ... Caremark, Express Scripts and Optum Rx deny their practices contribute to higher prices, and characterize the FTC ...

The PBM industry is dominated by three companies — Cigna’s Express Scripts, UnitedHealth Group’s Optum Rx and ... the price of insulin, PBMs dropped the medicine from their list of covered ...

PBMs dodged a bullet when those changes — which included transparency requirements, a ban on “spread pricing” and a provision delinking PBM payments from a drug’s list price — were ...

Time is slipping away from lawmakers who hope to resurrect a slate of changes to the pharmacy benefit manager (PBM) industry. PBMs dodged a bullet when those changes — which included transparency ...

The FDA had approved Otulfi in September 2024 to treat Crohn’s disease, ulcerative colitis, psoriasis and active psoriatic arthritis. Information on pricing is not yet available.

We recently compiled a list of the 30 Best Stocks To Invest In According to Billionaires. In this article, we are going to ...

Our members on average pay less than $25, far below list prices and far below the Biden ... member” pays only “$22 per month.” Optum RX says, “These baseless actions demonstrate a profound ...